Results 91 to 100 of about 7,788 (192)

INTRA VITREOUS BEVACIZUMAB VERSUS OBSERVATION IN ACUTE CENTRAL SEROUS CHORIORETINOPATHY.

open access: yesJournal of University Medical & Dental College, 2018
: OBJECTIVE: To compare the efficacy of intravitreal bevacizumab for absorption of sub-retinal fluid in central serus chorio retinopathy from observation alone.
Bassam Mubarik   +2 more
doaj  

Epinephrine, but not dexamethasone, induces apoptosis in human retinal pigment epithelium cells in vitro: Possible implications on the pathogenesis of central serous chorioretinopathy

open access: yesPhilippine Journal of Ophthalmology, 2004
Objective: The pathogenesis of central serous chorioretinopathy is poorly understood. It is believed to be due to dysfunction of the retinal pigment epithelium and/or choroid, and has been associated with elevated levels of epinephrine and administration
Santiago Antonio B. Sibayan, MD, PhD   +6 more
doaj  

Annual Incidence of Idiopathic Central Serous Chorioretinopathy, 2001–2006.

open access: yes, 2013
Annual Incidence of Idiopathic Central Serous Chorioretinopathy, 2001–2006.
Tseng-Ji Chen (425659)   +10 more
core   +1 more source

Central Serous Chorioretinopathy Associated with Rowatinex Usage

open access: yesEurasian Journal of Medicine, 2019
Central serous chorioretinopathy (CSC) is an idiopathic disorder characterized by serous detachment of the neurosensory retina. This report describes a case of CSC associated with rowatinex usage.
İlknur Akyol-Salman   +4 more
doaj  

Forgotten exogenous corticosteroid as a cause of central serous chorioretinopathy

open access: yes, 2008
Paul W Hardwig1, Amila O Silva2, Jose S Pulido11Department of Ophthalmology, Mayo Clinic, Rochester, MN, USA; 2Kaiser Permanente Fontana Medical Center, Fontana, CA, USAAbstract: Central serous chorioretinopathy (CSCR) is an idiopathic ocular condition ...
Jose S Pulido   +2 more
core  

Continuous Eplerenone Treatment in Chronic Central Serous Chorioretinopathy: Long-Term Results from a Pilot Study

open access: yes, 2023
Giacomo Boscia,1,* Pasquale Viggiano,1,* Federica Marzulli,1 Maria Oliva Grassi,1 Pasquale Puzo,1 Stefano Dore,2 Antonio Pinna,2 Giovanni Alessio,1 Francesco Boscia1 1Department of Translational Biomedicine Neuroscience, University of Bari “Aldo ...
Grassi MO   +8 more
core  

Therapeutic interventions for chronic central serous chorioretinopathy: a comprehensive assessment of systematic reviews

open access: yesInternational Journal of Retina and Vitreous
Background A variety of different treatments have been proposed to effectively treat chronic central serous chorioretinopathy but there remains uncertainty regarding the efficacy of a number of treatment options.
Henok Getahun, Rajendra S. Apte
doaj   +1 more source

Oral mineralocorticoid antagonists for recalcitrant central serous chorioretinopathy

open access: yes, 2015
Eric K Chin, David RP Almeida, C Nathaniel Roybal, Philip I Niles, Karen M Gehrs, Elliott H Sohn, H Culver Boldt, Stephen R Russell, James C FolkDepartment of Ophthalmology and Visual Sciences, University of Iowa, Iowa City, IA, USAPurpose: To evaluate ...
Russell SR   +8 more
core  

Chronic central serous chorioretinopathy: long-term follow-up and vision-related quality of life

open access: yes, 2016
Myrte B Breukink,1,* Alexander JM Dingemans,1,* Anneke I den Hollander,1,2 Jan EE Keunen,1 Robert E MacLaren,3,4 Sascha Fauser,5 Giuseppe Querques,6 Carel B Hoyng,1 Susan M Downes,3,4 Camiel JF Boon1,7 1Department of Ophthalmology, 2Department of Human ...
Breukink MB   +9 more
core  

Navigated focal laser photocoagulation for central serous chorioretinopathy

open access: yes, 2014
Jay Chhablani,1 Padmaja Kumari Rani,1 Annie Mathai,1 Subhadra Jalali,1 Igor Kozak2 1Srimati Kanuri Santhamma Vitreo-Retina Service, L V Prasad Eye Institute, Hyderabad, India; 2Division of Vitreoretinal Diseases and Surgery, King Khaled Eye ...
Mathai A   +4 more
core  

Home - About - Disclaimer - Privacy